Inhibikase Therapeutics (IKT.US) Shareholders - Institutional Holders, Major Shareholders & Insiders | Longbridge

Shareholder Type

Institutions61.11%
Public and others21.09%
VC/PE firms7.15%
Hedge funds5.97%
Others4.67%

Major Shareholders

Major Shareholders Latest
Shareholder
Sands Capital Alternatives, LLC	7.15%	13.02M	0.49%	+0	06/30/2026
Soleus Capital Management, L.P.	5.97%	10.88M	0.41%	+0	06/30/2026
Trails Edge Capital Partners, LP	4.97%	9.05M	0.24%	+993.97K	06/30/2026
Fairmount Funds Management LLC	4.74%	8.63M	0.32%	+0	06/30/2026
BlackRock, Inc.	4.27%	7.77M	0.57%	+1.46M	06/30/2026
ADAR1 Capital Management, LLC	4.06%	7.39M	0.18%	+780.63K	06/30/2026
RA Capital Management, L.P.	3.83%	6.97M	--	+6.97M	07/29/2026
Blackstone Alternative Asset Management L.P.	3.26%	5.94M	0.22%	+0	03/31/2026
Blackstone Alternative Investment Advisors LLC	3.26%	5.94M	3.26%	+5.94M	06/30/2026
Artal Group S.A.	3.21%	5.85M	0.22%	+0	06/30/2026
Sp Ikt Holdings Llc	3.21%	5.84M	0.22%	+0	04/15/2026
Vanguard Capital Management, LLC	3.04%	5.54M	0.10%	+524.95K	06/30/2026
Commodore Capital LP	2.96%	5.40M	0.20%	+0	06/30/2026
Millennium Management LLC	2.21%	4.03M	0.49%	+1.10M	06/30/2026
Saturn V Capital Management LP	2.12%	3.87M	0.14%	+5.61K	06/30/2026
Kalehua Capital Management LLC	2.10%	3.82M	0.14%	+0	06/30/2026
Spruce Street Capital LP	1.97%	3.58M	0.13%	+0	06/30/2026
Armistice Capital LLC	1.94%	3.53M	0.13%	+0	12/31/2024
Squadron Capital Management LLC	1.65%	3.00M	0.41%	-500.00K	06/30/2026
Nantahala Capital Management, LLC	1.48%	2.70M	0.10%	+0	06/30/2026